Because TFR is overexpressed in a variety of tumor cells, TF/TFR-mediated cell events have been used to deliver therapeutic drugs to malignant tumor cells (Tros de Ilarduya and Düzgüneş, 2013). The gene discussed is TF; the disease is neoplasm.